Brown J D, Doe R P
JAMA. 1978 Sep 15;240(12):1273-8. doi: 10.1001/jama.240.12.1273.
Pituitary control of pigmentation has known for more than 60 years. Since 1969, beta-melanocyte-stimulating hormone (beta-MSH) has been accepted as the main pituitary pigmentary hormone in man. Its "constant companionship" with adrenocorticotrophic hormone (ACTH) has also been repeatedly demonstrated. Current investigations challenge both of these concepts. Human beta-MSH immunoreactivity has been shown to be actually due to beta-lipotropic hormone (beta-LPH), a larger molecule that within itself contains the entire amino acid sequence of beta-MSH. Human beta-MSH does not exist in vivo; it is merely an extraction artifact formed by enzymatic degradation of beta-LPH. It would appear likely that beta-LPH, not beta-MSH, is the constant companion of ACTH.
垂体对色素沉着的控制已有60多年的认知历史。自1969年以来,β-促黑素细胞激素(β-MSH)一直被认为是人类垂体中主要的色素沉着激素。它与促肾上腺皮质激素(ACTH)的“始终相伴”也已得到反复证实。目前的研究对这两个概念都提出了挑战。已表明人类β-MSH免疫反应性实际上是由于β-促脂解激素(β-LPH),一种更大的分子,其自身包含β-MSH的完整氨基酸序列。人体内不存在β-MSH;它仅仅是由β-LPH酶促降解形成的一种提取假象。似乎很可能是β-LPH,而非β-MSH,是ACTH的始终相伴者。